We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$427M
AUM Growth
+$4.69M
Cap. Flow
+$1.94M
Cap. Flow %
0.45%
Top 10 Hldgs %
56.98%
Holding
37
New
6
Increased
10
Reduced
14
Closed
4

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$17.3M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$11.5M
3
BMY icon
Bristol-Myers Squibb
BMY
+$10.3M
4
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$7.72M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.09M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$12.9M
2
A icon
Agilent Technologies
A
+$9.6M
3
LLY icon
Eli Lilly
LLY
+$9.24M
4
RDY icon
Dr. Reddy's Laboratories
RDY
+$6.31M
5
ACOR
Acorda Therapeutics
ACOR
+$6.19M

Sector Composition

Rank Sector Weight
1 Healthcare 85.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$49.9M 11.68%
770,147
-146,000
-16% -$9.24M
BAX icon
2
Baxter International
BAX
$11.7B
$36.7M 8.59%
942,224
-55,230
-6% -$2.24M
BSX icon
3
Boston Scientific
BSX
$65.4B
$30.1M 7.04%
2,547,600
+30,000
+1% +$378K
EW icon
4
Edwards Lifesciences
EW
$49.4B
$24.2M 5.67%
1,423,800
-378,000
-21% -$5.97M
TEVA icon
5
Teva Pharmaceuticals
TEVA
$37.3B
$18.3M 4.28%
340,600
+6,000
+2% +$318K
RVTY icon
6
Revvity
RVTY
$12.3B
$17.3M 4.05%
397,460
+2,000
+0.5% +$91.1K
SYK icon
7
Stryker
SYK
$123B
$17M 3.97%
+210,183
New +$17.3M
DGX icon
8
Quest Diagnostics
DGX
$23.3B
$16.9M 3.96%
279,128
-4,000
-1% -$246K
THOR
9
DELISTED
THORATEC CORPORATION
THOR
$16.8M 3.93%
628,300
+70,000
+13% +$1.99M
BMY icon
10
Bristol-Myers Squibb
BMY
$124B
$16.2M 3.8%
317,000
+207,000
+188% +$10.3M
CAH icon
11
Cardinal Health
CAH
$53.5B
$15M 3.51%
200,000
-7,000
-3% -$509K
IRWD icon
12
Ironwood Pharmaceuticals
IRWD
$635M
$14.7M 3.45%
1,359,119
-24,119
-2% -$276K
LPNT
13
DELISTED
LifePoint Health, Inc.
LPNT
$13.8M 3.23%
199,700
– –
THC icon
14
Tenet Healthcare
THC
$16.8B
$13.6M 3.19%
229,500
-48,700
-18% -$2.72M
CBST
15
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$13.3M 3.1%
199,990
+7,500
+4% +$493K
RMD icon
16
ResMed
RMD
$28.9B
$11.4M 2.67%
231,300
-18,000
-7% -$917K
PDCO
17
DELISTED
Patterson Companies, Inc.
PDCO
$10.7M 2.51%
258,465
– –
WCG
18
DELISTED
Wellcare Health Plans, Inc.
WCG
$10.4M 2.44%
+173,145
New +$11.5M
HSP
19
DELISTED
HOSPIRA INC
HSP
$10.4M 2.43%
200,000
-33,800
-14% -$1.79M
BIO icon
20
Bio-Rad Laboratories Class A
BIO
$8.15B
$8.74M 2.05%
77,100
+10,800
+16% +$1.28M
VRTX icon
21
Vertex Pharmaceuticals
VRTX
$123B
$8.36M 1.96%
+74,463
New +$7.09M
COR icon
22
Cencora
COR
$59.9B
$7.58M 1.77%
98,000
-2,000
-2% -$152K
CYH icon
23
Community Health Systems
CYH
$465M
$6.08M 1.42%
+134,310
New +$5.58M
ACOR
24
DELISTED
Acorda Therapeutics
ACOR
$5.98M 1.4%
1,472
-1,650
-53% -$6.19M
VOLC
25
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$5.93M 1.39%
+557,000
New +$7.72M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2014 Portfolio in Review

As of Q3 2014, Sector Gamma AS held 37 positions worth $427M, up 1.1% from $423M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sector Gamma AS's Q3 2014 filing shows 6 new, 10 increased, 14 reduced and 4 closed positions. Its largest new stake was Stryker: 210,183 shares worth $17M. The largest sale was AbbVie, an estimated $12.9M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 88% a quarter earlier.

  • Sector Gamma AS's largest Q3 2014 buy was Stryker: 210,183 shares worth $17M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q3 2014, an estimated $10.3M increase.
  • Sector Gamma AS's biggest Q3 2014 reduction was Eli Lilly, cutting an estimated $9.24M.
  • Sector Gamma AS fully exited AbbVie in Q3 2014, selling an estimated $12.9M.
  • Sector Gamma AS's ten largest holdings make up 57% of its $427M portfolio in Q3 2014.
  • Sector Gamma AS opened 6 new positions and closed 4 in Q3 2014.
  • Sector Gamma AS's portfolio value rose 1.1% quarter-over-quarter to $427M.

Based on Sector Gamma AS's 13F filing for Q3 2014, filed 13 Nov 2014.